In this online CME self-learning program:
Severe septicemia or sepsis results from an exaggerated response of the body to infection. This devastating condition can be triggered by a bacterial, viral, parasitic or fungal infection, often the result of events such as trauma, surgery and burns, or illnesses such as cancer, urinary tract infection and pneumonia. There are an estimated 750,000 cases of severe sepsis in the U.S. every year. Approximately 215,000 (28.6%) of these patients die every year. According to statistics provided by the American Heart Association, this is significantly higher than the number of people in the US who die of stroke and acute myocardial infarction each year. Severe sepsis also has extraordinary cost implications. It accounts for nearly 40% of all ICU costs, with total annual costs of $16.7 billion in the U.S. alone. This program defines the sepsis continuum incidence and mortality rates for severe sepsis, the pathogenesis of sepsis, the multidisciplinary approach to sepsis management, and presents case studies.
This program has been designed for a multidisciplinary physician and nurse audience including: Emergency Medicine / ICU / Anesthesia / Peri-op / Intensivists / Trauma / Critical Care
Supported through an educational grant from Edwards Lifesciences
Release Date: November 15, 2011 -- Expiration Date: November 15, 2014
Faculty: Pat Posa, RN, BSN, MSA
By the end of the session the participant will be able to:
This program has expired. You may view it, but no CME will be offered.
As an accredited provider of continuing medical education, it is the policy of the ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is not to prevent a person with a significant financial or other relationship from participating in CME activities, but rather to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity: for this CME activity, any COI has been resolved thru content review by ScientiaCME.
Pat Posa RN, BSN, MSA reports receiving grant and travel expense support, and being a consultant / speakers bureau member / and speaker with honorarium from Edwards Lifesciences.
Disclosures of Educational Planners: Steven Sachse is an officer and part owner of ScientiaCME, LLC. ScientiaCME has received grants from Bayer, Edwards Lifesciences, Eisai, Daiichi-Sankyo, Lilly, Merck, Pfizer, Sanofi Aventis, Wolf-Torey Medical.
The entire faculty for this program has reported that they will not discuss unapproved drug or device uses.
Commercial Support Disclosure: Supported through an educational grant from Edwards Lifesciences.
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.